82 related articles for article (PubMed ID: 1990712)
1. Humoral tolerance in mixed xenogeneic chimeras prepared by a nonmyeloablative conditioning regimen.
Aksentijevich I; Sharabi Y; Sundt TM; Sachs DH; Sykes M
Transplant Proc; 1991 Feb; 23(1 Pt 1):880-2. PubMed ID: 1990712
[No Abstract] [Full Text] [Related]
2. Mechanism of tolerance in mixed xenogeneic chimeras prepared with a nonmyeloablative conditioning regimen.
Lee LA; Sergio JJ; Sachs DH; Sykes M
Transplant Proc; 1994 Jun; 26(3):1197-8. PubMed ID: 8029884
[No Abstract] [Full Text] [Related]
3. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
Ito H; Takeuchi Y; Shaffer J; Sykes M
Transplantation; 2006 Jul; 82(2):251-7. PubMed ID: 16858289
[TBL] [Abstract][Full Text] [Related]
4. Xenogeneic (rat to mouse) skin tolerance induced by monoclonal antibodies, xenogeneic cells, and cyclophosphamide.
Umesue M; Mayumi H; Nishimura Y; Kong YY; Omoto K; Murakami Y; Nomoto K; Nomoto K
Transplant Proc; 1995 Feb; 27(1):315-6. PubMed ID: 7879018
[No Abstract] [Full Text] [Related]
5. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
[TBL] [Abstract][Full Text] [Related]
6. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.
Aksentijevich I; Sachs DH; Sykes M
Transplantation; 1992 May; 53(5):1108-14. PubMed ID: 1585475
[TBL] [Abstract][Full Text] [Related]
7. Mixed xenogeneic chimerism (mouse+rat-->mouse) to induce donor-specific tolerance to sequential or simultaneous islet xenografts.
Li H; Ricordi C; Demetris AJ; Kaufman CL; Korbanic C; Hronakes ML; Ildstad ST
Transplantation; 1994 Feb; 57(4):592-8. PubMed ID: 8116047
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts.
Gammie JS; Li S; Zeevi A; Demetris AJ; Ildstad ST; Pham SM
Circulation; 1998 Nov; 98(19 Suppl):II163-8; discussion II168-9. PubMed ID: 9852899
[TBL] [Abstract][Full Text] [Related]
9. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
Colson YL; Zadach K; Nalesnik M; Ildstad ST
Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
[TBL] [Abstract][Full Text] [Related]
10. Fully and long-term xenogeneic hematopoietic chimeras created in poorly concordant rat-mouse combinations: expression of hereditary donor characteristics.
Spach C; Lucchiari N; Bureaud N; Motta R
Exp Hematol; 1995 Oct; 23(11):1192-203. PubMed ID: 7556530
[TBL] [Abstract][Full Text] [Related]
11. Transplantation tolerance following conditioning with C1q-affinity anti-Thy-1 monoclonal antibodies.
Thierfelder S; Kummer U; Schuh R
Transplant Proc; 1987 Feb; 19(1 Pt 1):459-61. PubMed ID: 3274806
[No Abstract] [Full Text] [Related]
12. Application of chimerism-based drug-induced tolerance to rat into mouse xenotransplantation.
Tomita Y; Shimizu I; Iwai T; Zhang QW; Okano S; Kajiwara T; Onzuka T; Tominaga R
Scand J Immunol; 2006 Oct; 64(4):392-7. PubMed ID: 16970680
[TBL] [Abstract][Full Text] [Related]
13. Prolongation of skin xenograft survival with concomitant donor bone marrow transplantation.
Jeyarajah DR; Schmeisser FS; Kadakia RA; Thistlethwaite JR
Transplant Proc; 1994 Jun; 26(3):1201-2. PubMed ID: 8029886
[No Abstract] [Full Text] [Related]
14. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen.
Tomita Y; Khan A; Sykes M
J Immunol; 1994 Aug; 153(3):1087-98. PubMed ID: 8027542
[TBL] [Abstract][Full Text] [Related]
15. Effect of natural antibody on xenogeneic bone marrow engraftment.
Sykes M; Sachs DH; Aksentijevich I
Transplant Proc; 1992 Apr; 24(2):497-8. PubMed ID: 1566403
[No Abstract] [Full Text] [Related]
16. Effect of rapamycin on islet and skin xenograft survival.
Bobbio SA; Porter JG; Monaco AP
Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
[No Abstract] [Full Text] [Related]
17. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
18. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
[TBL] [Abstract][Full Text] [Related]
19. Cross-species transplantation tolerance: rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor V beta in chimeras tolerant to xenogeneic antigens (mouse + rat----mouse).
Ildstad ST; Vacchio MS; Markus PM; Hronakes ML; Wren SM; Hodes RJ
J Exp Med; 1992 Jan; 175(1):147-55. PubMed ID: 1530958
[TBL] [Abstract][Full Text] [Related]
20. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
Masaki H; Appel MC; Leahy L; Leif J; Paquin L; Shultz LD; Mordes JP; Greiner DL; Rossini AA
Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
